Pathogenesis of autoimmune myositis: Role of MHC Class 1

自身免疫性肌炎的发病机制:MHC 1 类的作用

基本信息

  • 批准号:
    7186420
  • 负责人:
  • 金额:
    $ 21.9万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2005
  • 资助国家:
    美国
  • 起止时间:
    2005-04-01 至 2010-01-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Specific therapies are not currently available for systemic autoimmune rheumatic diseases. Development of specific and effective therapies requires the definition of pathways important in the disease pathogcncsis. The MHC class 1 mouse model of myositis is a powerful tool to identify such pathways. The long term goals of this proposal are to define the molecular pathways responsible for the skeletal muscle damage and dysfunction in autoimmune myositis. The MHC class I transgenic mice develop several features of human autoimmune polymyositis including myositis-specific autoantibodies. Preliminary experiments showed that the absence of lymphocytes and macrophages only partially ameliorates muscle fiber damage and dysfunction suggesting that over-expression of MHC class I in myofibers also initiates a specific sequence of ceil autonomous (myofiber) pathways leading to muscle damage. Thus, in this model both immune cells and skeletal muscle cells appear to play a role in the manifestation of full blown autoimmune myositis. Therefore, we propose that skeletal muscle cell damage in MHC class I expressing muscle fibers can partly be induced by cytotoxic T lymphocytes and partly by perturbation of intracellular homeostasis (ER stress response). Our preliminary experiments clearly show that the ER stress response pathway is highly up-regulated in both human myositis and in the mouse model. Defining the contribution of mechanisms of ER stress response and NF-kB pathways in MHC class I-expressing fibers and their role in muscle fiber damage and dysfunction is a major priority of this proposal. This hypothesis is pursued by a) blocking critical members of ER stress response pathway and NF-kB pathways in vivo, and b) identifying novel immune and non-immune pathways mediating muscle fiber damage and dysfunction by gene and protein expression profiling. The proposed aims will not only define predominant mechanisms of muscle fiber damage and dysfunction in vivo in transgenic mice but will also potentially identify new targets for therapeutic intervention in human myositis.
描述(由申请人提供):

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

KANNEBOYINA NAGARAJU其他文献

KANNEBOYINA NAGARAJU的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('KANNEBOYINA NAGARAJU', 18)}}的其他基金

Virus induced genetic changes in the pathogenesis of autoimmune myositis
病毒诱导自身免疫性肌炎发病机制的遗传变化
  • 批准号:
    9226076
  • 财政年份:
    2017
  • 资助金额:
    $ 21.9万
  • 项目类别:
Dystrophin turnover after exon-skipping
外显子跳跃后肌营养不良蛋白的周转
  • 批准号:
    9293874
  • 财政年份:
    2016
  • 资助金额:
    $ 21.9万
  • 项目类别:
Preclinical drug trial in mouse models of inflammation
炎症小鼠模型的临床前药物试验
  • 批准号:
    8690993
  • 财政年份:
    2011
  • 资助金额:
    $ 21.9万
  • 项目类别:
Preclinical drug trial in mouse models of inflammation
炎症小鼠模型的临床前药物试验
  • 批准号:
    8242218
  • 财政年份:
    2011
  • 资助金额:
    $ 21.9万
  • 项目类别:
Preclinical drug trial in mouse models of inflammation
炎症小鼠模型的临床前药物试验
  • 批准号:
    8325061
  • 财政年份:
    2011
  • 资助金额:
    $ 21.9万
  • 项目类别:
Pathogenesis of autoimmune myositis: Role of MHC Class 1
自身免疫性肌炎的发病机制:MHC 1 类的作用
  • 批准号:
    7903812
  • 财政年份:
    2009
  • 资助金额:
    $ 21.9万
  • 项目类别:
Pathogenesis of autoimmune myositis: Role of MHC Class 1
自身免疫性肌炎的发病机制:MHC 1 类的作用
  • 批准号:
    7197328
  • 财政年份:
    2005
  • 资助金额:
    $ 21.9万
  • 项目类别:
Pathogenesis of autoimmune myositis: Role of MHC Class 1
自身免疫性肌炎的发病机制:MHC 1 类的作用
  • 批准号:
    7391060
  • 财政年份:
    2005
  • 资助金额:
    $ 21.9万
  • 项目类别:
Pathogenesis of autoimmune myositis: Role of MHC Class 1
自身免疫性肌炎的发病机制:MHC 1 类的作用
  • 批准号:
    6926751
  • 财政年份:
    2005
  • 资助金额:
    $ 21.9万
  • 项目类别:
Pathogenesis of autoimmune myositis: Role of MHC Class 1
自身免疫性肌炎的发病机制:MHC 1 类的作用
  • 批准号:
    7576722
  • 财政年份:
    2005
  • 资助金额:
    $ 21.9万
  • 项目类别:

相似海外基金

Elucidating a molecular understanding of ILC2 MHC class I antigen cross priming
阐明 ILC2 MHC I 类抗原交叉引发的分子理解
  • 批准号:
    486527
  • 财政年份:
    2022
  • 资助金额:
    $ 21.9万
  • 项目类别:
    Studentship Programs
Restoring MHC class I antigen presentation to enhance anti-tumour immunity
恢复MHC I类抗原呈递,增强抗肿瘤免疫力
  • 批准号:
    nhmrc : GNT1164054
  • 财政年份:
    2020
  • 资助金额:
    $ 21.9万
  • 项目类别:
    Project Grants
Subversion of MHC class I antigen presentation by viral immunomodulatory proteins
病毒免疫调节蛋白颠覆 MHC I 类抗原呈递
  • 批准号:
    8996707
  • 财政年份:
    2014
  • 资助金额:
    $ 21.9万
  • 项目类别:
Ubiquitin conjugation and direct MHC class I antigen presentation
泛素结合和直接 MHC I 类抗原呈递
  • 批准号:
    8880646
  • 财政年份:
    2014
  • 资助金额:
    $ 21.9万
  • 项目类别:
Subversion of MHC class I antigen presentation by viral immunomodulatory proteins
病毒免疫调节蛋白颠覆 MHC I 类抗原呈递
  • 批准号:
    9206412
  • 财政年份:
    2014
  • 资助金额:
    $ 21.9万
  • 项目类别:
Subversion of MHC class I antigen presentation by viral immunomodulatory proteins
病毒免疫调节蛋白颠覆 MHC I 类抗原呈递
  • 批准号:
    8723605
  • 财政年份:
    2014
  • 资助金额:
    $ 21.9万
  • 项目类别:
MHC Class I Antigen Presentation in Viral Infections
病毒感染中 MHC I 类抗原呈递
  • 批准号:
    8072956
  • 财政年份:
    2010
  • 资助金额:
    $ 21.9万
  • 项目类别:
The function of the Ubiquitin-Proteasome-System (UPS) in MHC class I antigen processing in target cells and maturing human dendritic cells (hDCs).
泛素蛋白酶体系统 (UPS) 在靶细胞和成熟人树突细胞 (hDC) 中 MHC I 类抗原加工中的功能。
  • 批准号:
    105348415
  • 财政年份:
    2009
  • 资助金额:
    $ 21.9万
  • 项目类别:
    Research Grants
In vivo analysis of the imnportance of proteasome immunosubunits and of PA28 for MHC class I antigen processing, CTL response induction and tumor-virus elimination (A 7)
体内分析蛋白酶体免疫亚基和 PA28 对于 MHC I 类抗原加工、CTL 反应诱导和肿瘤病毒消除的重要性 (A 7)
  • 批准号:
    5354871
  • 财政年份:
    2002
  • 资助金额:
    $ 21.9万
  • 项目类别:
    Collaborative Research Centres
MHC Class I Antigen Presentation in Viral Infections
病毒感染中 MHC I 类抗原呈递
  • 批准号:
    7991835
  • 财政年份:
    2001
  • 资助金额:
    $ 21.9万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了